Incidence of milrinone blood levels outside the therapeutic range and their relevance in children after cardiac surgery for congenital heart disease

[1] Bishara T(2010)Use of milrinone in critically ill children Can J Hosp Pharm 63 420-428

[2] Seto WTW(2003)Efficacy and safety of milrinone in preventing low cardiac output syndrome in infants and children after corrective surgery for congenital heart disease Circulation 107 996-1002

[3] Trope A(1986)Myocardial actions of milrinone: characterization of its mechanism of action Circulation 73 134-144

[4] Parshuram Ch(1986)Inhibition of cyclic AMP-dependent protein kinase activity by the cardiotonic drugs amrinone and milrinone Life Sci 39 1901-1908

[5] Hoffman TM(1986)Pharmacology of the bipyridines: amrinone and milrinone Circulation 73 III10-III24

[6] Wernovsky G(1986)Inotropic effects of amrinone and milrinone on contraction and relaxation of isolated cardiac muscle Circulation 73 III25-III35

[7] Atz AM(1989)Pharmacology of positive inotropic phosphodiesterase III inhibitors Eur Heart J 10 25-31

[8] Rapundalo ST(1986)Phosphodiesterase-inhibiting properties of newer inotropic agents Circulation 73 III99-III108

[9] Grupp I(1986)Effects of new inotropic agents on cyclic nucleotide metabolism and calcium transients in canine ventricular muscle Circulation 73 III117-III133

[10] Grupp G(1987)In vitro vascular relaxation by new inotropic agents: relationship to phosphodiesterase inhibition and cyclic nucleotides J Pharmacol Exp Ther 242 864-872

[1] Bishara T(2010)Use of milrinone in critically ill children Can J Hosp Pharm 63 420-428

[2] Seto WTW(2003)Efficacy and safety of milrinone in preventing low cardiac output syndrome in infants and children after corrective surgery for congenital heart disease Circulation 107 996-1002

[3] Trope A(1986)Myocardial actions of milrinone: characterization of its mechanism of action Circulation 73 134-144

[4] Parshuram Ch(1986)Inhibition of cyclic AMP-dependent protein kinase activity by the cardiotonic drugs amrinone and milrinone Life Sci 39 1901-1908

[5] Hoffman TM(1986)Pharmacology of the bipyridines: amrinone and milrinone Circulation 73 III10-III24

[6] Wernovsky G(1986)Inotropic effects of amrinone and milrinone on contraction and relaxation of isolated cardiac muscle Circulation 73 III25-III35

[7] Atz AM(1989)Pharmacology of positive inotropic phosphodiesterase III inhibitors Eur Heart J 10 25-31

[8] Rapundalo ST(1986)Phosphodiesterase-inhibiting properties of newer inotropic agents Circulation 73 III99-III108

[9] Grupp I(1986)Effects of new inotropic agents on cyclic nucleotide metabolism and calcium transients in canine ventricular muscle Circulation 73 III117-III133

[10] Grupp G(1987)In vitro vascular relaxation by new inotropic agents: relationship to phosphodiesterase inhibition and cyclic nucleotides J Pharmacol Exp Ther 242 864-872